Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet    (SUNP)


New Research: Our #1 Stock Pick Right Now


Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 702.7
Mkt Cap Rs m 1,691,105
Vol '000 268.8
P/E X 87.6
P/CF X 27.1
EPS (TTM) Rs 8.0
% ch % -0.7
No. of shares m 2,406.75
% ch week % 8.9
% ch 1-mth % 13.5
% ch 12-mth % 51.7
52 week H/L Rs 721.9/434.3
(As on May 12, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs1,201842701679484 
Low Rs706572433375315 
Sales per share (Unadj.) Rs118.4131.6110.4121.1136.9 
Earnings per share (Unadj.) Rs23.532.710.713.417.5 
Diluted earnings per shareRs23.532.610.713.317.4 
Cash flow per share (Unadj.) Rs27.837.917.020.726.0 
Dividends per share (Unadj.) Rs1.003.502.002.754.00 
Adj. dividends per shareRs1.003.491.992.743.99 
Dividend yield (eoy) %0.10.50.40.51.0 
Book value per share (Unadj.) Rs137.1152.7159.7172.6188.7 
Adj. book value per shareRs137.0152.2159.2172.1188.1 
Shares outstanding (eoy) m2,406.602,399.262,399.262,399.262,399.26 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x8.15.45.14.42.9 
Avg P/E ratio x40.621.753.039.422.9 
P/CF ratio (eoy) x34.318.633.425.515.4 
Price / Book Value ratio x7.04.63.53.12.1 
Dividend payout %4.310.718.720.622.9 
Avg Mkt Cap Rs m2,294,8131,696,8771,360,0211,264,650958,864 
No. of employees `00014.717.517.817.517.8 
Total wages/salary Rs m47,72349,02353,67159,67163,624 
Avg. sales/employee Rs Th19,317.218,028.314,890.916,608.118,490.6 
Avg. wages/employee Rs Th3,236.12,798.83,017.13,409.63,582.6 
Avg. net profit/employee Rs Th3,836.94,473.81,443.61,833.82,357.6 
SUN PHARMA INCOME DATA
Net Sales Rs m284,870315,784264,895290,659328,375 
Other income Rs m6,5836,2328,38810,2556,360 
Total revenues Rs m291,453322,016273,282300,914334,735 
Gross profit Rs m81,583100,89356,08163,07669,898 
Depreciation Rs m10,37512,64814,99817,53320,528 
Interest Rs m5,2323,9985,1765,5533,027 
Profit before tax Rs m72,55890,47944,29550,24652,702 
Minority Interest Rs m00000 
Prior Period Items Rs m150000 
Extraordinary Inc (Exp) Rs m-6,8520-9,505-12,144-2,606 
Tax Rs m9,13812,1169,1106,0098,228 
Profit after tax Rs m56,58378,36325,67932,09341,868 
Gross profit margin %28.631.921.221.721.3 
Effective tax rate %12.613.420.612.015.6 
Net profit margin %19.924.89.711.012.8 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m299,413329,537316,359310,692316,542 
Current liabilities Rs m131,440178,870198,643173,396157,064 
Net working cap to sales %59.047.744.447.248.6 
Current ratio x2.31.81.61.82.0 
Inventory Days Days8279959988 
Debtors Days Days8783108112105 
Net fixed assets Rs m180,477204,766213,178232,477243,102 
Share capital Rs m2,4072,3992,3992,3992,399 
"Free" reserves Rs m327,418363,997380,742411,691450,245 
Net worth Rs m329,825366,397383,141414,091452,645 
Long term debt Rs m31,10314,36117,72115,22620,289 
Total assets Rs m555,303614,102645,164646,938682,525 
Interest coverage x14.923.69.610.018.4 
Debt to equity ratio x0.10000 
Sales to assets ratio x0.50.50.40.40.5 
Return on assets %11.113.44.85.86.6 
Return on equity %17.221.46.77.89.2 
Return on capital %19.724.810.010.211.2 
Exports to sales %13.90000 
Imports to sales %3.10000 
Exports (fob) Rs m39,5720000 
Imports (cif) Rs m8,8820000 
Fx inflow Rs m42,17144,11851,40366,02574,219 
Fx outflow Rs m21,58324,48432,23338,61027,964 
Net fx Rs m20,58819,63419,17027,41546,255 
SUN PHARMA CASH FLOW
From Operations Rs m 66,859 70,822 39,072 21,965 65,548 
From Investments Rs m -43,716 -42,216 -33,708 -6,813 -25,888 
From Financial Activity Rs m -18,885 -22,854 -15,393 -27,305 -57,151 
Net Cashflow Rs m 8,482 6,107 -7,359 -8,442 -13,857 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.6

Read: SUN PHARMA 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   GSK PHARMA  FDC  AMAR REMEDIES  JUBILANT PHARMOVA   ELDER PHARMA  

Compare SUN PHARMA With:   GSK PHARMA  FDC  AMAR REMEDIES  JUBILANT PHARMOVA   ELDER PHARMA  

Compare SUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - ADCOCK INGRAM COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS